In-Clinic Diagnostics vs. Reference Lab Testing: What Veterinary Practices Should Consider

The in-clinic vs. reference lab question comes up in almost every practice at some point. It's rarely a simple calculation, but it's also not as complicated as it sometimes feels.

What Reference Labs Do Well

Reference labs exist for good reasons. They offer a broad test menu, highly consistent analytical quality, and access to specialized testing that most practices couldn't replicate in-house economically. For exotic species, complex panels, cytology, pathology, and low-volume specialized tests, reference labs are often the right answer. They're also predictable: you send a sample, you get a result, you pay a per-test fee.

Where In-Clinic Diagnostics Add Clinical Value

The case for in-clinic testing is strongest in high-frequency, time-sensitive scenarios:

Emergency and urgent cases. A patient presenting with suspected anemia, metabolic crisis, or organ dysfunction needs results now. Reference lab turnaround — even with rush options — is measured in hours, not minutes. In-clinic results change the clinical decision in real time.

Pre-anesthetic workups. CBC and chemistry panels before elective procedures are standard of care. Doing them in-clinic the morning of a procedure is faster and avoids the scheduling complexity of pre-procedure reference lab draws.

Monitoring cases. Patients on medications that require regular blood monitoring — chemotherapy, phenobarbital, thyroid management — are often seen frequently. In-clinic testing makes those visits more efficient for staff and patients.

High-volume routine testing. For practices doing significant volumes of wellness bloodwork, the per-test economics of in-clinic testing can compare favorably to reference lab fees at sufficient volume.

The Economic Calculation

The rough economic test: at my current (or projected) test volume, does the per-test cost of in-clinic testing — including equipment, consumables, QC, and staff time — come out favorably against what I'm currently paying the reference lab?

That calculation requires real numbers. The variables are: current reference lab spend on the tests you'd bring in-house, projected in-clinic cost per test (equipment amortization + consumables + QC + labor), and volume at which in-clinic breaks even. This isn't a calculation that should be done with vendor-provided estimates alone.

The Right Mix Is Practice-Specific

Very few practices should be 100% in-clinic or 100% reference lab. The right answer is a mix that plays to the strengths of each. Most independent practices that benefit from in-clinic diagnostics run routine CBC and chemistry in-house for their highest-frequency use cases, while continuing to use reference labs for specialized testing, pathology, and panels that don't justify the in-clinic equipment investment.

The evaluation question isn't "should I replace my reference lab" — it's "which tests make clinical and economic sense to do in-clinic, given my volume and patient mix?"